$84.21
1.52% yesterday
Nasdaq, May 20, 10:10 pm CET
ISIN
US4523271090
Symbol
ILMN

Illumina Stock price

$84.21
+12.21 16.96% 1M
-47.47 36.05% 6M
-49.42 36.98% YTD
-21.53 20.36% 1Y
-153.02 64.50% 3Y
-264.33 75.84% 5Y
-112.57 57.21% 10Y
Nasdaq, Closing price Tue, May 20 2025
+1.26 1.52%
ISIN
US4523271090
Symbol
ILMN
Sector
Industry

Key metrics

Market capitalization $13.33b
Enterprise Value $14.70b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 16.78
EV/Sales (TTM) EV/Sales 3.39
P/S ratio (TTM) P/S ratio 3.07
P/B ratio (TTM) P/B ratio 5.65
Revenue growth (TTM) Revenue growth -3.47%
Revenue (TTM) Revenue $4.34b
EBIT (operating result TTM) EBIT $1.42b
Free Cash Flow (TTM) Free Cash Flow $876.00m
Cash position $1.24b
EPS (TTM) EPS $-6.10
P/E forward 22.85
P/S forward 3.16
EV/Sales forward 3.48
Short interest 5.39%
Show more

Is Illumina a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Illumina Stock Analysis

Unlock Scores for Free

Analyst Opinions

26 Analysts have issued a Illumina forecast:

10x Buy
38%
14x Hold
54%
2x Sell
8%

Analyst Opinions

26 Analysts have issued a Illumina forecast:

Buy
38%
Hold
54%
Sell
8%

Financial data from Illumina

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
4,337 4,337
3% 3%
100%
- Direct Costs 1,458 1,458
16% 16%
34%
2,879 2,879
4% 4%
66%
- Selling and Administrative Expenses 73 73
93% 93%
2%
- Research and Development Expense 1,073 1,073
20% 20%
25%
1,733 1,733
377% 377%
40%
- Depreciation and Amortization 315 315
27% 27%
7%
EBIT (Operating Income) EBIT 1,418 1,418
2,185% 2,185%
33%
Net Profit -965 -965
25% 25%
-22%

In millions USD.

Don't miss a Thing! We will send you all news about Illumina directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Illumina Stock News

Neutral
Business Wire
one day ago
FOSTER CITY, Calif.--(BUSINESS WIRE)--Signios Biosciences (“Signios Bio”), a science-first biotechnology company leading in multiomics and AI-powered bioinformatics, in collaboration with Illumina, announced today an Illumina-sponsored grant for Early Access to Illumina Protein Prep 9.5K™. Powered by SOMAmer® technology, this next-generation sequencing (NGS)-based platform enables comprehensive...
Neutral
PRNewsWire
7 days ago
SAN DIEGO , May 14, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: 41st Annual Bernstein Strategic Decisions Conference on May 28, 2025 Fireside chat at 11:30am Pacific Time (2:30pm Eastern Time) The webcast can be accessed through the Investor Info section of Illumina's website at investor.illumina.c...
Neutral
PRNewsWire
8 days ago
Building on reputation for unparalleled performance, latest software delivers even greater accuracy, with 30% improvement in structural variant calling New features include easy-to-use oncology apps, enhanced multiomics pipelines, and AWS F2 support enabling faster turnaround times SAN DIEGO , May 13, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN) today announced the launch of DRAGEN™ versio...
More Illumina News

Company Profile

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Head office United States
CEO Jacob Thaysen
Employees 10,370
Founded 1998
Website www.illumina.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today